Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

- In vitro skin corrosion (OECD 431, GLP): non-corrosive


- In vitro skin irritation (OECD 439, GLP): non-irritant


- In vitro eye irritation (OECD 437, GLP): non-irritant

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
16 - 22 Nov 2021
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Version / remarks:
adopted in 2021
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Cell source:
other: EPISKIN Small Model™ (EPISKIN-SM™)
Source strain:
other: not applicable (human skin model)
Details on animal used as source of test system:
not applicable (human skin model)
Justification for test system used:
The used test system is in line with OECD 439.
Vehicle:
unchanged (no vehicle)
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EPISKIN Small Model™ (EPISKIN-SM™), EPISKIN, Lyon, France
- Tissue batch number(s): 21-EKIN-046
- Suggested expiration date: 22 Nov 2021
- Date of initiation of testing: 16 Nov 2021

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature
- Temperature of post-treatment incubation: 37° ± 1.0 °C (5% CO2 and 80 - 100% relative humidity)

REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: At the end of the exposure period, the test item was washed from the skin surface with Phosphate buffered saline (PBS). No information on volume given.
- Observable damage in the tissue due to washing: not reported

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 0.3 mg/mL
- Incubation time: 3 h
- Spectrophotometer: Tecan Infinite M200 Pro Plate Reader
- Wavelength: 570 nm

FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Histology: A histological evaluation of the human epidermis was provided in the Certificate of Analysis of the EPISKIN Small Model™. An HES stained paraffin section demonstrated that the model was satisfactory and described as "Multi-layered, highly differentiated epidermis consisting of organized basal, spinous and granular layers, and multilayered stratum corneum". In addition, it consisted of 8 cell layers, which is in line with the determined specification (≥ 4 cell layers).
- Viability: A MTT cell viability test was performed by EpiSkin. The results were provided in the Certificate of Analysis of the EPISKIN Small Model™. The determined IC50 was 1.8 mg/mL, which is within the specified range of 1.5 mg/mL ≤ IC50 ≤ 3.0 mg/mL.
- Contamination: EpiSkin verified the absence of HIV1 and 2 antibodies, hepatitis C antibodies, and hepatitis B antigen HBs in the blood of the donors. In addition, EpiSkin verified the absence of bacteria, fungus, and mycoplasma on the cells form the donors.

NUMBER OF REPLICATE TISSUES
3 tissues were used per treatment, negative, and positive control (12 tissues in total).

CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
The test item has been tested previously for possible direct MTT reduction and color interference in the skin corrosion test using Epiderm as a Skin Model™ (Report no. 20326170). The solutions were not turned blue / purple nor a blue / purple precipitate was observed in the presence of MTT, therefore it was concluded that the test item did not interfere with the MTT endpoint. The Optical Density (OD) for the test item solution was ≤ 0.08, therefore it was concluded that the test item did not interact with the MTT measurement.

NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
single experiment

PREDICTION MODEL / DECISION CRITERIA
- According to the EU and GHS classification, an irritant is predicted if the mean relative tissue viability of three individual tissues exposed to the test substance is reduced below or equal to 50% of the mean viability of the negative controls.
mean tissue viability ≤ 50% Irritant (I), (CLP / GHS Category 2)
mean tissue viability > 50% non-irritant (NI).
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied: 25 µL

NEGATIVE CONTROL
- Amount(s) applied: 25 µL

POSITIVE CONTROL SUBSTANCE:
- Amount(s) applied: 25 µL
- Concentration: 5% aqueous solution
Duration of treatment / exposure:
15 ± 0.5 min at room temperature
Duration of post-treatment incubation (if applicable):
42 ± 1 h at 37 °C
Number of replicates:
3 for treatment and control groups
Irritation / corrosion parameter:
% tissue viability
Remarks:
mean value of 3 tissues (percentage of control)
Run / experiment:
15 min exposure
Value:
103
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
OTHER EFFECTS:
- Direct-MTT reduction: No direct interaction with the MTT assay reagent was observed.
- Colour interference with MTT: The test item has been tested previously for possible direct MTT reduction and color interference in the skin corrosion test using Epiderm as a Skin Model™ (Report no. 20326170). The solutions were not turned blue / purple nor a blue / purple precipitate was observed in the presence of MTT, therefore it was concluded that the test item did not interfere with the MTT endpoint. The Optical Density (OD) for the test item solution was ≤ 0.08, therefore it was concluded that the test item did not interact with the MTT measurement.
- Visible damage on test system: not reported

DEMONSTRATION OF TECHNICAL PROFICIENCY:
No demonstration of proficiency shown in the study report. However, the acceptance criteria were all met (see below) and the optical density (OD) values of the negative and positive controls are all within the historical control value ranges, indicating that the test system functioned properly.

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The mean OD of the tissue replicates treated with the negative control was ≥ 0.6 and ≤ 1.5 (value: 1.157, see 'Any other information on results incl. tables', table 1).
- Acceptance criteria met for positive control: The mean viability of the tissue replicates treated with the positive control was < 40% compared to the negative control (value: 2.5%, see 'Any other information on results incl. tables', table 2).
- Acceptance criteria met for standard deviation: The standard deviation calculated from individual % tissue viabilities of the 3 identically treated replicates was below the limit of acceptance of 18% (< 9%, refer to table 2).

HISTORICAL CONTROL DATA
See 'Any other information on results incl. tables', table 4.

Table 1: Mean Absorption in the In Vitro Skin Irritation Test









































 



A (OD570)



B (OD570)



C (OD570)



Mean (OD570)



± SD



Negative control



1.046



1.181



1.243



1.157



0.101



Test item



1.164



1.254



1.150



1.189



0.056



Positive control



0.026



0.031



0.029



0.028



0.003



OD = Optical density


SD = Standard deviation


Triplicate exposures are indicated by A, B, and C.


Values are corrected for background absorption (0.044). Isopropanol was used to measure the background absorption.



 


Table 2: Mean Tissue Viability in the In Vitro Skin Irritation Test





























 



Mean tissue viability (percentage of control)



± SD (percentage)



Negative control



100



8.7



Test item



103



4.9



Positive control



2.5



0.2



SD = Standard deviation



 


Table 3: Individual OD Measurements at 570 nm




























































 



A (OD570)



B (OD570)



C (OD570)



Negative control



OD570 measurement 1



1.0475



1.1989



1.2956



OD570 measurement 2



1.1326



1.2517



1.2792



Test item



OD570 measurement 1



1.1743



1.3139



1.2163



OD570 measurement 2



1.2426



1.2817



1.1722



Positive control



OD570 measurement 1



0.0682



0.0739



0.0692



OD570 measurement 2



0.0713



0.0755



0.0771



OD = Optical density


Triplicate exposures are indicated by A, B, and C.



 


Table 4: Historical Control Data for In Vitro Skin Irritation Studies (Data Collection Period From May 2018 To May 2021)


































 



Negative control (absorption; OD570)



Positive control (absorption; OD570)



Range



0.507 - 1.478



0.026 - 0.549



Mean



1.060



0.106



SD



0.153



0.085



n



159



159



SD = Standard deviation


n = Number of observations


Interpretation of results:
other: Non-irritant
Conclusions:
Under the present test conditions, Esterification products of fatty acids, C18 (unsaturated) alkyl and adipic acid with pentaerythritol tested at an exposure time of 15 min and a 42 h post-treatment incubation period, was a non-irritant to reconstructed human epidermis tissue in the EPISKIN Small Model™.
Endpoint:
skin corrosion: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
21 Sep - 24 Sep 2021
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
Version / remarks:
adopted in 2019
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Cell source:
other: EpiDerm™ Skin Model (EPI-200)
Source strain:
other: not applicable (human skin model)
Details on animal used as source of test system:
not applicable (human skin model)
Justification for test system used:
The used test system is in line with OECD 431.
Vehicle:
unchanged (no vehicle)
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™ (EPI-200) (MatTek Corporation, MA, USA)
- Tissue batch number(s): 35665
- Date of initiation of testing: 21 Sep 2021

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature (3-min exposure), 37 ± 1.0 °C (5% CO2 and 80 - 100% humidity; 1-h exposure)
- Temperature of post-treatment incubation: incubation with MTT assay solution at 37 ± 1.0 °C (5% CO2 and 80 - 100% humidity)

REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: At the end of the exposure period, the test item was carefully washed from skin surface with phosphate buffered saline (PBS). No information on volume given.
- Observable damage in the tissue due to washing: not reported

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL
- Incubation time: 3-h
- Spectrophotometer: TECAN Infinite® M200 Pro Plate Reader
- Wavelength: 570 nm

FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: A MTT cell viability test (4-h; n = 3) was performed by MatTek. The results were provided in the Certificate of Analysis of the EpiDerm™ Reconstructed Human Epidermis. The determined OD (540 - 570 nm) was 1.801 ± 0.03 (pass). The negative control tissue has been shown to be stable in culture (provided similar viability measurements) for the duration of the test exposure period (refer to 'Results and discussion' /'Test Acceptance Criteria'). The tissue employed has been shown to demonstrate reproductivity over time and between laboratories.

- Barrier function: A barrier function test was performed by MatTek. The results were provided in the Certificate of Analysis of the EpiDerm™ Reconstructed Human Epidermis. The barrier function was assessed by determination of the exposure time required to reduce tissue viability by 50% (ET-50) upon application of 100 µL of 1% Triton X-100. The ET-50 value was determined to be 5.17 h (pass).

- Morphology: The model consists of normal, human-derived epidermal keratinocytes which have been cultured to form a multilayered, highly differentiated model of the human epidermis. It consists of organized basal, spinous and granular layers, and a multi-layered stratum corneum containing intercellular lamellar lipid layers arranged in patterns analogous to those found in vivo. The EpiDerm tissues (surface 0.6 cm²) were cultured on polycarbonate membranes of 10 mm cell culture inserts.

- Contamination: A sterility test was performed by MatTek. The cells used to produce the EpiDerm™ tissue were screened long term in antibiotic and antimycotic free culture. No contamination was detected (specific contaminants not reported).

NUMBER OF REPLICATE TISSUES
2 tissues were used per treatment, negative and positive control included, and exposition time (12 tissues in total).

CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
No possible interference with the MTT measurement (OD 570 nm), due to colour changes or direct interacting with the MTT assay reagent, was noted. The solutions were not turned blue / purple nor a blue / purple precipitate was observed in the presence of MTT, therefore it was concluded that the test item did not interfere with the MTT endpoint. The OD for the test item solution was ≤ 0.08, therefore it was concluded that the test item did not interact with the MTT measurement. Therefore, no additional control tissues were needed.

NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
single experiment

PREDICTION MODEL / DECISION CRITERIA
- The test item is considered to be corrosive to skin if the viability after 3-min exposure is less than 50%. Additionally, CLP / GHS sub-category 1A if the viability after 3-min exposure is less than 25%.
- The test item is considered to be corrosive to skin if the viability after 3-min exposure is greater than or equal to 50% and the viability after 1-h exposure is less than 15%. Additionally, CLP / GHS sub-category 1B and 1C if the viability after 3-min exposure is greater than or equal to 25%.
- The test item is considered to be non-corrosive to skin, if the viability after 3-min exposure is greater than or equal to 50% and the viability after 1-h exposure is greater than or equal to 15%
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied: 50 µL

NEGATIVE CONTROL
- Amount(s) applied: 50 µL

POSITIVE CONTROL SUBSTANCE:
- Amount(s) applied: 50 µL
- Concentration: 8 N KOH
Duration of treatment / exposure:
3 and 60 min
Duration of post-treatment incubation (if applicable):
3h (for cell viability measurement)
Number of replicates:
2 tissues were used per treatment, negative and positive control included, and exposition time (12 tissues in total).
Irritation / corrosion parameter:
% tissue viability
Remarks:
mean value of 2 tissues (percentage of control)
Run / experiment:
3 min exposure
Value:
88
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Remarks:
mean value of 2 tissues (percentage of control)
Run / experiment:
60 min exposure
Value:
100
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
OTHER EFFECTS:
- Direct-MTT reduction: No direct interaction with the MTT assay reagent was observed.
- Colour interference with MTT: The test item was checked for color interference in aqueous conditions. Addition of the test item to Milli-Q and isopropanol resulted after subtraction of the blank in an OD of 0.0045 and 0.0128, respectively. Therefore it was concluded that the test item did not induce color interference.
- Visible damage on test system: not reported

DEMONSTRATION OF TECHNICAL PROFICIENCY:
No demonstration of proficiency shown in the study report. However, the acceptance criteria were all met (see below) and the optical densitiy (OD) values of the negative and positive controls are all within the historical control value ranges, indicating that the test system functioned properly.

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The mean optical density (OD) of the negative control of 2 tissues was 1.824 (3-min exposure) or 1.708 (1-h exposure) and was well within the acceptable range of ≥ 0.8 to ≤ 2.8 (see 'any other information on results incl. tables', table 1, respectively).
- Acceptance criteria met for positive control: The mean viability of cells treated with the positive reference item 8 N KOH was 6.4% or 9.0% (3-min or 1-h exposure, respectively) of the negative control and, hence well below the 15% cut-off value at the 1-h exposure (see 'any other information on results incl. tables', table 2, respectively).
- Acceptance criteria met for variability between replicate measurements: The difference of viability between the 2 tissue replicates (at 20 – 100% viability) was below the limit of acceptance of 30% (refer to table 3).

HISTORICAL CONTROL DATA
See 'Any other information on results incl. tables', table 5

Table 1: Mean Absorption in the in vitro Skin Corrosion Test

 

3-min application

1-h application

A (OD570)

B (OD570)

Mean (OD570)

± SD

A (OD570)

B (OD570)

Mean (OD570)

± SD

Negative control

1.960

1.688

1.824

0.193

1.707

1.709

1.708

0.001

Test item

1.540

1.686

1.613

0.103

1.732

1.684

1.708

0.034

Positive control

0.104

0.131

0.117

0.019

0.148

0.161

0.155

0.009

SD = Standard deviation

Duplicate exposures are indicated by A and B.

Values are corrected for background absorption (0.0424). Isopropanol was used to measure the background absorption.

 

Table 2: Mean Tissue Viability in the in vitro Skin Corrosion Test

 

3-min application viability (percentage of control)

1-h application viability (percentage of control)

Negative control

100

100

Test item

88

100

Positive control

6.4

9.0

 

Table 3: Coefficient of Variation between Tissue Replicates

 

3-min

1-h

Negative control

14

0.1

Test item

8.6

2.7

Positive control

21

8.0

CV (%) = 100 – [(lowest OD570 / highest OD570) x 100%]

 

Table 4: Individual OD Measurements at 570 nm

 

3-min application (OD570)

1-h application (OD570)

A

B

A

B

Negative control

OD570 measurement 1

2.0002

1.6996

1.7501

1.7549

OD570 measurement 2

1.9956

1.7627

1.7562

1.7390

OD570 measurement 3

2.0125

1.7283

1.7427

1.7591

Test item

OD570 measurement 1

1.5643

1.6853

1.7719

1.7350

OD570 measurement 2

1.5897

1.7439

1.7721

1.7292

OD570 measurement 3

1.5936

1.7550

1.7786

1.7161

Positive control

OD570 measurement 1

0.1452

0.1716

0.1893

0.2029

OD570 measurement 2

0.1469

0.1735

0.1919

0.2054

OD570 measurement 3

0.1460

0.1740

0.1902

0.2019

OD = Optical density

Duplicate exposures are indicated by A and B

 

Table 5: Historical Control Data for in vitro Skin Corrosion Studies (Data Collection Period From May 2018 to May 2021)

 

Negative control

Positive control

3-min application (OD570)

1-h application (OD570)

3-min application (OD570)

1-h application (OD570)

Range

1.375 - 2.226

1.317 - 2.182

0.080 - 0.512

0.032 - 0.319

Mean

1.718

1.746

0.161

0.132

SD

0.172

0.151

0.065

0.046

n

126

126

126

126

SD = Standard deviation

n = Number of observations

 

Interpretation of results:
other: non-corrosive
Conclusions:
Under the present test conditions, Esterification products of fatty acids, C18 (unsaturated) alkyl and adipic acid with pentaerythritol tested at two exposure periods of 3 min or 1 h was non-corrosive to reconstructed human epidermis tissue in the EpiDerm™ model. There is regulatory acceptance in the EU that a substance can be considered corrosive (Skin Corrosive Cat.1A) based on a positive result in the human epidermis model test. Negative in vitro corrosivity responses are not conclusive with respect to non-classification or classification as irritant and shall therefore be subject to further evaluation. A follow-up in vitro skin irritation test using the EPISKIN Small Model™ (Report no. 20326171) demonstrated no skin irritation.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records
Reference
Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
31 Aug 2021
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
Version / remarks:
adopted in 2020
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Species:
cattle
Strain:
not specified
Details on test animals or tissues and environmental conditions:
SOURCE OF COLLECTED EYES
- Source: obtained from slaughterhouse (Vitelco, 's-Hertogenbosch, The Netherlands)
- Characteristics of donor animals: young cattle; no further characteristics given in the report
- Storage, temperature and transport conditions of ocular tissue: Eyes were collected and transported in physiological saline in a suitable container under cooled conditions and tested the day of arrival in the laboratory. No further transport conditions given in the report.
- Indication of any existing defects or lesions in ocular tissue samples: no; only corneas from eyes free of defects were used
- Selection and preparation of corneas: The isolated corneas were stored in a petri dish with cMEM (Eagle’s Minimum Essential Medium (Life Technologies, Bleiswijk, The Netherlands) containing 1% (v/v) L-glutamine (Life Technologies) and 1% (v/v) Foetal Bovine Serum (Life Technologies)). The isolated corneas were mounted in a corneal holder (one cornea per holder) of Duratec Analysentechnik GmbH (Hockenheim, Germany) with the endothelial side against the O-ring of the posterior half of the holder. The anterior half of the holder was positioned on top of the cornea and tightened with screws. The compartments of the corneal holder were filled with cMEM of 32 ± 1°C. The corneas were incubated for the minimum of 1-h at 32 ± 1°C.
- Quality check of the isolated corneas: After the incubation period, the medium was removed from both compartments and replaced with fresh cMEM. Opacity determinations were performed on each of the corneas using an opacitometer (BASF-OP3.0, Duratec GmbH). The opacity of each cornea was read against a cMEM filled chamber, and the initial opacity reading thus determined was recorded. Corneas that had an initial opacity reading higher than 7 were not used. Three corneas were selected at random for each treatment group.
Vehicle:
unchanged (no vehicle)
Controls:
yes, concurrent positive control
yes, concurrent negative control
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied: 750 µL (also for neg. and pos. controls)
Duration of treatment / exposure:
10 ± 1 min
Observation period (in vivo):
Not applicable
Duration of post- treatment incubation (in vitro):
120 ± 10 min
Number of animals or in vitro replicates:
Triplicates for each treatment and control group
Details on study design:
TREATMENT METHOD
- The medium from the anterior compartment was removed and 750 µL of either the negative control, positive control (ethanol) or test item was introduced onto the epithelium of the cornea. The holders were slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the control or the test item over the entire cornea. Corneas were incubated in a horizontal position for 10 ± 1 min at 32 ± 1°C.

REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: After the incubation the solutions were removed and the epithelium was washed with MEM with phenol red (Eagle’s Minimum Essential Medium, Life Technologies) and thereafter with cMEM. Possible pH effects of the test item on the corneas were recorded.

POST-EXPOSURE INCUBATION:
After the washing steps, the medium in the posterior compartment was removed and both compartments were refilled with fresh cMEM. Subsequently the corneas were incubated for 120 ± 10 min at 32 ± 1 °C. After the completion of the incubation period opacity determination was performed. Each cornea was inspected visually for dissimilar opacity patterns.

METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: Corneal opacity was determined by the diminution of light passing through the cornea measured quantitatively via an opacitometer (BASF-OP3.0, Duratec GmbH). The change in opacity for each individual cornea (including the negative control) was calculated by subtracting the initial opacity reading from the final post-treatment reading. The corrected opacity for each cornea treated with the test item or positive control was calculated by subtracting the average change in opacity of the negative control corneas from the change in opacity of each test item or positive control treated cornea. The mean opacity value of each treatment group was calculated by averaging the corrected opacity values of the treated corneas for each treatment group.
- Corneal permeability: Following the final opacity measurement, permeability of the cornea to Na-fluorescein (Sigma-Aldrich, Germany) was evaluated. The medium of both compartments (anterior compartment first) was removed. The posterior compartment was refilled with fresh cMEM. The anterior compartment was filled with 1 mL of 4 mg Na-fluorescein (Sigma-Aldrich Chemie GmbH, Germany) / mL cMEM solution. The holders were slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the sodium-fluorescein solution over the entire cornea. Corneas were incubated in a horizontal position for 90 ± 5 minutes at 32 ± 1 °C. After the incubation period, the medium in the posterior compartment of each holder was removed and placed into a sampling tube labelled according to holder number. 360 μL of the medium from each sampling tube was transferred to a 96-well plate. The optical density at 490 nm (OD490) of each sampling tube was measured in triplicate using a microplate reader (TECAN Infinite® M200 Pro Plate Reader).

SCORING SYSTEM:
In Vitro Irritancy Score (IVIS)

DECISION CRITERIA:
Test substance with an IVIS > 55 was regarded as serious eye damage and labelled Category 1 according to CLP / GHS, respectively.
Test substance with an IVIS ≤ 3 was regarded as non-irritant and labelled in no category.
Test substance with an IVIS > 3; ≤ 55 no prediction can be made.
Irritation parameter:
in vitro irritation score
Remarks:
mean value of 3 corneas
Run / experiment:
10 min exposure
Value:
0
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
OTHER EFFECTS:
- Visible damage on test system: not reported
- There were no pH effects.

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes, the negative control resulted in mean opacity (3.0) and permeability (0.003) values that were less than the established upper limits for background opacity and permeability values for bovine corneas treated with the respective negative control (see 'Any other information on results incl. tables', table 1 and 6).
- Acceptance criteria met for positive control: Yes, the positive control resulted in an IVIS (55) which was within two standard deviations of the current historical mean (see 'Any other information on results incl. tables', table 1 and 6).

HISTORICAL CONTROL DATA
See 'Any other information on results incl. tables', table 6

Table 1: Summary of Opacity, Permeability and In Vitro Scores

































Treatment



Mean opacity1



Mean permeability1



Mean in vitro irritation score1,2



Negative control



3.0



0.003



3.0



Positive control



23



2.079



55



Test item



0.0



-0.001



0.0



1 Calculated using the negative control corrected mean opacity and mean permeability values for the positive control and test item.


2 In vitro irritancy score (IVIS) = mean opacity value + (15 x mean OD490 value).



 


Table 2: Opacity Scores











































































Treatment



Opacity before treatment



Opacity after treatment



Final opacity1



Negative control corrected final opacity2



Mean final opacity



Negative control



0.1



3.1



3.0



 



3.0



1.1



3.9



2.8



0.6



3.8



3.2



Positive control



1.4



29



27



24



23



1.7



21



19



16



1.5



35



33



30



Test item



-0.1



3.9



4.0



1.0



0.0



-0.2



3.0



3.2



0.2



-0.6



1.2



1.8



-1.2



Calculations are made without rounding off.


1 Final Opacity = Opacity after treatment – Opacity before treatment.


2 Negative control corrected Final Opacity = Final opacity – Mean final opacity negative control.



 


Table 3: Permeability Score Individual Values (Uncorrected)

































































































Treatment



Dilution factor



OD490 1



OD490 2



OD490 3



Average OD



Final OD



Mean final negative control



Negative control



1



-0.003



-0.001



-0.002



-0.002



-0.002



0.003



1



0.013



0.015



0.017



0.015



0.015



1



-0.005



-0.003



-0.007



-0.005



-0.005



Positive control



6



0.632



0.428



0.447



0.502



3.014



 



1



1.168



1.161



1.146



1.158



1.158



8



0.361



0.364



0.324



0.350



2.098



Test item



1



0.006



0.009



0.003



0.006



0.006



 



1



0.002



0.001



0.001



0.002



0.002



1



0.001



-0.005



-0.005



-0.003



-0.003



Calculations are made without rounding off.



 


Table 4: Permeability Score Individual Values (Corrected)







































































Treatment



Dilution factor



Negative control corrected OD490 11



Negative control corrected OD490 21



Negative control corrected OD490 31



Negative control corrected Average OD490



Negative control corrected Final OD490



Average OD



Positive control



6



0.629



0.425



0.444



0.500



2.998



2.079



1



1.165



1.158



1.143



1.156



1.156



6



0.358



0.361



0.321



0.347



2.082



Test item



1



0.003



0.006



0.000



0.003



0.003



-0.001



1



-0.001



-0.002



-0.002



-0.001



-0.001



1



-0.002



-0.008



-0.008



-0.006



-0.006



Calculations are made without rounding off.


1 OD490 values corrected for the mean final negative control permeability (0.003).



 


Table 5: In Vitro Irritancy Scores (IVIS)































































Treatment



Final Opacity2



Final OD4902



IVIS score1



Negative control



3.0



-0.002



3.0



2.8



0.015



3.0



3.2



-0.005



3.1



Positive control



24



2.998



69



16



1.156



34



30



2.082



61



Test item



1.0



0.003



1.0



0.2



-0.001



0.2



-1.2



-0.006



-1.2



1 In vitro irritancy score (IVIS) = opacity value + (15 x OD490 value).


2 Positive control and test item are corrected for the negative control.



 


Table 6: Historical Control Data for the BCOP Studies (Data Collection Period From May 2018 To May 2021)
























































 



Negative control



Positive control



 



Opacity



Permeability



IVIS



IVIS



Min



-2.50



-0.017



-2.50



26



Max



3.70



0.065



4.00



86



Mean



0.86



0.002



0.89



50



SD



1.26



0.009



1.28



14



n



143



143



143



143



IVIS = In vitro irritancy score


SD = Standard deviation


n = Number of observations


Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
Conclusions:
Under the present test conditions, Esterification products of fatty acids, C18 (unsaturated) alkyl and adipic acid with pentaerythritol tested at an exposure time of 10 min and a 120 min post-treatment incubation period, was a non-irritant to bovine eyes in the Bovine Corneal Opacity and Permeability (BCOP) test. Application of the test substance to bovine corneas resulted in a calculated mean IVIS of 0.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Skin corrosion


The potential of Esterification products of fatty acids, C18 (unsaturated) alkyl and adipic acid with pentaerythritol to induce skin irritation was examined in vitro according to OECD 431 (EpiDerm™ skin model) and GLP principles (Charles River, 2022b). The test item was applied undiluted (50 µL), directly on top of reconstructed human epidermis (RhE) tissue for 3 min and 1 h. Determination of the cytotoxic (corrosion) effect was performed by the MTT cell viability assay. Skin corrosion is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after 3 min and 1 h treatment with the test item compared to the negative control tissues was 88% and 100%, respectively. Since the mean relative tissue viability for the test item was above 50% after 3 min treatment and above 15% after 1 h treatment, the test item is considered to be non-corrosive. The positive control had a mean cell viability of 9% after 1 h exposure and was considered valid. The mean OD570 (optical density at 570 nm) values of the negative control tissues were ≥ 0.8 and ≤ 2.8 for every exposure time. The difference of viability between the 2 tissue replicates (at 20 – 100% viability) was below the limit of acceptance of 30%, indicating that the test system functioned properly. In conclusion, the test item is a non-corrosive in the in vitro skin corrosion test under the experimental conditions described.


 


Skin irritation


The potential of Esterification products of fatty acids, C18 (unsaturated) alkyl and adipic acid with pentaerythritol to induce skin irritation was examined in vitro according to OECD 439 (EPISKIN™ Small model (EPISKIN-SM™)) and GLP principles (Charles River, 2022c). The test item was applied undiluted (25 µL), directly on top of reconstructed human epidermis (RhE) tissue for 15 ± 0.5 min. After a 42 ± 1 h post-incubation period, determination of the cytotoxic (irritancy) effect was performed. Cytotoxicity was measured by the MTT cell viability assay. Skin irritation is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after 15 ± 0.5 min treatment with the test item (and 42 ± 1 h post-incubation period) compared to the negative control tissues was 103%. Since the mean relative tissue viability for the test item was above 50% after 15 ± 0.5 min treatment the test item is considered to be non-irritant. The positive control had a mean cell viability of 2.5% after 15 ± 0.5 min exposure and was considered valid. The absolute mean OD570 (optical density at 570 nm) of the negative control tissues was within the laboratory historical control data range. The standard deviation value of the percentage viability of three tissues treated identically was < 9%, indicating that the test system functioned properly. In conclusion, the test item is a non-irritant in the in vitro skin irritation test under the experimental conditions described.


 


Conclusion:
Based on the available in vitro skin corrosion and skin irritation data, it can be concluded that Esterification products of fatty acids, C18 (unsaturated) alkyl and adipic acid with pentaerythritol is a non-irritant and no classification according to the CLP Regulation (EC) No. 1272/2008 is required.


 


Eye irritation


The potential of Esterification products of fatty acids, C18 (unsaturated) alkyl and adipic acid with pentaerythritol to induce eye irritation was examined in vitro according to OECD 437 (Bovine Corneal Opacity and Permeability Test) and GLP principles (Charles River, 2021a). For this purpose 750 µL of the undiluted test substance was topically applied to bovine corneas for 10 ± 1 min. After exposure the corneas were thoroughly rinsed to remove the test item and transferred to fresh medium for incubation (120 ± 10 min) prior to the determination of the irritancy effect. Corneal opacity was determined by the diminution of light passing through the cornea measured quantitatively via an opacitometer at 490 nm. Corneal permeability was determined by the passage of sodium fluorescein dye measured quantitatively with the aid of a microplate reader (OD490). An in-vitro irritancy score (IVIS) was then calculated based on the corneal opacity and permeability values (IVIS = mean opacity value + (15 x mean permeability OD490 value)). Three tissues for each treatment and control group were examined. Since the mean IVIS for the test item (0) was ≤ 3, the test item is considered to be a non-irritant. The positive control, ethanol, had a mean IVIS of 55 and was considered valid (within two standard deviations of the current historical mean). The negative control, saline, resulted in mean opacity (3.0) and permeability (0.003) values that were less than the established upper limits for background opacity and permeability values for bovine corneas treated with the respective negative control, indicating that the test system functioned properly. In conclusion, the test item is a non-irritant in the in vitro eye irritation test under the experimental conditions described and no classification is required according to CLP Regulation (EC) No. 1272/2008.

Justification for classification or non-classification

The available in vitro data on skin irritation/corrosion and eye irritation conducted with the registration substance do not meet the classification criteria according to the CLP Regulation (EC) No. 1272/2008 and are therefore conclusive but not sufficient for classification.